NCT03354754View on ClinicalTrials.gov

LYS228 PK, Clinical Response, Safety and Tolerability in Patients With Complicated Intra-abdominal Infection (cIAI)

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

May 15, 2018

Primary Completion Date

September 24, 2018

Study Completion Date

September 24, 2018

Conditions
Intra-abdominal Infections
Interventions
DRUG

LYS228

LYS228 IV infusion every 6 hours

DRUG

Standard of care therapy

IV infusion of standard of care antibiotics

Trial Locations (1)

08230

Novartis Investigative Site, Somers Point

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY